Session Details

Long-term therapy: obstacles to be addressed
29 Aug 08:30 - 10:00 Drug therapy Abstract Session Brussels - Zone D
Chairpersons: Juan Luis TAMARGO (Madrid, ES), Keld Per KJELDSEN (Copenhagen, DK)

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

Presentations list

Related documents
08:301907Long-term follow-up of the patients with Aspirin resistant end stage kidney disease Cuneyt KOCAS (Istanbul, TR)
08:451908Good short-term but not long-term reproducibility of the antiplatelet efficacy laboratory assessmentJan VOJACEK (Prague 4, CZ)
09:001909Prevention of peptic ulcers with once-daily esomeprazole 20 mg and 40 mg in low-dose acetylsalicylic acid users at gastrointestinal risk: outcome analysis by cardiovascular risk (OBERON)James SCHEIMAN (Ann Arbor, US)
09:151910Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes mellitus and renal impairment - the FIELD studyRu-Dee TING (Balmain, AU)
09:301911Long-term effects of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease and the metabolic syndromeHideki WATANABE (Joso, JP)
09:451912Effective management of glycosylated hemoglobin levels with niacin extended release among patients with type II diabetes mellitusRobert SIMKO (Chicago, US)

Who we are

What we do

How we work

More ESC